Mitchell & Pahl Private Wealth LLC Boosts Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Mitchell & Pahl Private Wealth LLC boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 8,518 shares of the medical device company’s stock after purchasing an additional 532 shares during the period. Mitchell & Pahl Private Wealth LLC’s holdings in Cooper Companies were worth $783,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Ashton Thomas Securities LLC purchased a new stake in shares of Cooper Companies in the third quarter worth about $25,000. Covestor Ltd lifted its holdings in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares during the period. Brown Brothers Harriman & Co. boosted its position in Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after purchasing an additional 275 shares in the last quarter. Friedenthal Financial acquired a new stake in shares of Cooper Companies during the 3rd quarter worth approximately $50,000. Finally, Cromwell Holdings LLC purchased a new position in shares of Cooper Companies during the 3rd quarter valued at approximately $52,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company increased their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Citigroup reduced their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $93.27 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The firm has a market capitalization of $18.61 billion, a PE ratio of 47.83, a P/E/G ratio of 2.36 and a beta of 0.99. The business’s 50 day moving average price is $96.34 and its 200-day moving average price is $99.13.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter last year, the firm posted $0.87 EPS. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.